Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psilocybin PFM
NCT04501653Phase 1Completed
- Sponsor
- Washington University School of Medicine
- Start
- Jun 2021
- Primary completion
- Mar 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of psilocybin (2 arms), sponsored by Washington University School of Medicine. Primary endpoint: Functional Connectivity at 1 week. Started Jun 2021; status: completed.
02
Drugs
psilocybin
Beyond the preview
Go deeper on NCT04501653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04501653.